Neurosoft Bioelectronics

About:

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system.

Website: https://www.neurosoft-bio.com

Twitter/X: NeurosoftBio

Top Investors: Venture Kick, European Innovation Council, Innosuisse, MassChallenge, FONGIT Innovation Fund

Description:

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system. Neural implants are medical devices made of electrodes that can record or stimulate the brain, spinal cord, or peripheral nerves to monitor or treat patients suffering from neurological disorders. However, current clinical devices are too stiff compared to the soft tissues of the body, which limits benefits for patients. At Neurosoft Bioelectronics, we have developed a new generation of soft and conformable implantable electrodes that seamlessly interface with the nervous tissues and can improve clinical outcomes for patients.

Total Funding Amount:

2.96M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Geneva, Geneve, Switzerland

Founded Date:

2019-02-01

Contact Email:

contact(AT)neurosoft-bio.com

Founders:

Nicolas Vachicouras

Number of Employees:

1-10

Last Funding Date:

2023-04-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai